2MW-4991

N/A

Report date: 2024/03/29 13:40:01

Base Information

Drug Name2MW-4991
Drug Alias Name2MW-49912MW4991
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of Actionintegrin alpha V/beta 8 blockersAntibody-dependent cell-mediated cytotoxicity (ADCC) effects
Targetsintegrin alpha V/beta 8
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesMabwell (Shanghai) Bioscience Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMabwell (Shanghai) Bioscience Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A